BACE-1is a trans-membrane aspartyl protease and the rate-limiting enzyme initiating amyloidogenic APP processing [4].Compared to healthy individuals, AD patients demonstrate elevated BACE-1 expression and enzymatic activity levels in the brain[5]. The gene discussed is APP; the disease is Alzheimer disease.